Dr. Howard 'Skip' Burris III Shares His Views on Clinical Trial Eligibility Criteria, Payer Involvement

FDA Fosters Understanding about Approval Process for Biosimilars

Oncologic Biologic Biosimilars Are Coming to Market: Are You Ready?

Breaking News Briefs

Breaking News Briefs

AACR 2018: First-Line Management of Advanced NSCLC Enters New Era

PD-L1 IHC Blueprint Project: Ongoing Progress Toward Consistency Among Assays

2017 Lung Cancer SPORE Workshop

FDA’s New Nicotine-Focused Regulatory Framework Supported by Evidence Reviews on Electronic Cigarettes

Q&A with Dr. D. Ross Camidge

Keeping It Personal: CMS-Proposed Coverage Restrictions for NGS Challenge Innovation in Personalized Care

Breaking News Briefs